FDA Drug recall D-0514-2019
Mometasone Furoate Cream, 0.1%, 45 g tube, Rx Only, Manufactured by: G&W Laboratories, Inc
- FDA Drug
- Class III
- terminated
- Published 2019-02-27
On 2019-02-27 the FDA classified a Class III recall of Mometasone Furoate Cream, 0.1%, 45 g tube, Rx Only, Manufactured by: G&W Laboratories, Inc by Acp Nimble Buyer, citing labeling: Not Elsewhere Classified. Mometasone Furoate Cream has an NDC typographical error.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0514-2019 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2019-02-07 |
| Published | 2019-02-27 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Acp Nimble Buyer |
| Distribution | US |
Product
Mometasone Furoate Cream, 0.1%, 45 g tube, Rx Only, Manufactured by: G&W Laboratories, Inc. South Plainfield, NJ 07080, NDC 0713-0726-37
Reason
Labeling: Not Elsewhere Classified. Mometasone Furoate Cream has an NDC typographical error.
Identifiers
| code_info | Lot #: 1009431, 1009507, Exp. 08/2020; 1009886, Exp. 09/2020 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0514-2019%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.